tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

SRPT Stock Latest News

Sarepta reports positive ELEVIDYS protein expression data in young patients
The FlySarepta reports positive ELEVIDYS protein expression data in young patients
3d ago
SRPT
Sarepta presents EMBARK study data at ASGCT conference
PremiumThe Fly
Sarepta presents EMBARK study data at ASGCT conference
3d ago
SRPT
Sarepta Therapeutics: Hold Rating Amid Limited Financial Gains from ELEVIDYS Approval and Market Adoption Concerns
PremiumRatings
Sarepta Therapeutics: Hold Rating Amid Limited Financial Gains from ELEVIDYS Approval and Market Adoption Concerns
5d ago
SRPT
Sarepta announces Japan approval for Elevidys
PremiumThe Fly
Sarepta announces Japan approval for Elevidys
6d ago
SRPT
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
11d ago
BOLT
HRTX
Trump announces trade deal, BoE lowers Bank Rate: Morning Buzz
PremiumThe FlyTrump announces trade deal, BoE lowers Bank Rate: Morning Buzz
11d ago
Z
SN
Uber downgraded, Rockwell Automation upgraded: Wall Street’s top analyst calls
Premium
The Fly
Uber downgraded, Rockwell Automation upgraded: Wall Street’s top analyst calls
11d ago
ADM
AWR
Sarepta downgraded to In Line from Outperform at Evercore ISI
Premium
The Fly
Sarepta downgraded to In Line from Outperform at Evercore ISI
11d ago
SRPT
Sarepta Therapeutics: Buy Rating Maintained Amid Growth Potential and Valuation Opportunity
PremiumRatings
Sarepta Therapeutics: Buy Rating Maintained Amid Growth Potential and Valuation Opportunity
11d ago
SRPT
Sarepta Therapeutics’ Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Sarepta Therapeutics’ Earnings Call: Growth Amid Challenges
11d ago
SRPT
Sarepta price target lowered to $125 from $183 at Needham
PremiumThe Fly
Sarepta price target lowered to $125 from $183 at Needham
12d ago
SRPT
Sarepta price target lowered to $58 from $87 at RBC Capital
PremiumThe Fly
Sarepta price target lowered to $58 from $87 at RBC Capital
12d ago
SRPT
Morning Movers: Disney jumps after first quarter earnings, Abu Dhabi resort plan
PremiumThe FlyMorning Movers: Disney jumps after first quarter earnings, Abu Dhabi resort plan
12d ago
U
AMD
Sarepta price target lowered to $123 from $184 at Oppenheimer
Premium
The Fly
Sarepta price target lowered to $123 from $184 at Oppenheimer
12d ago
SRPT
Sarepta price target lowered to $60 from $193 at Baird
Premium
The Fly
Sarepta price target lowered to $60 from $193 at Baird
12d ago
SRPT
Sarepta price target lowered to $98 from $112 at Guggenheim
PremiumThe Fly
Sarepta price target lowered to $98 from $112 at Guggenheim
12d ago
SRPT
Long-Term Potential and Strategic Developments Drive Buy Rating for Sarepta Therapeutics Despite Short-Term Challenges
PremiumRatings
Long-Term Potential and Strategic Developments Drive Buy Rating for Sarepta Therapeutics Despite Short-Term Challenges
12d ago
SRPT
Sarepta price target lowered to $70 from $110 at Piper Sandler
PremiumThe Fly
Sarepta price target lowered to $70 from $110 at Piper Sandler
12d ago
SRPT
Sarepta Therapeutics: Buy Rating Affirmed Amid Revenue Challenges and Strategic Adjustments
PremiumRatings
Sarepta Therapeutics: Buy Rating Affirmed Amid Revenue Challenges and Strategic Adjustments
12d ago
SRPT
Sarepta Therapeutics: Buy Rating Affirmed Amidst Strong Growth and Strategic Resilience
PremiumRatingsSarepta Therapeutics: Buy Rating Affirmed Amidst Strong Growth and Strategic Resilience
12d ago
SRPT
Sarepta Therapeutics: Buy Rating Affirmed Despite Challenges and Market Adjustments
Premium
Ratings
Sarepta Therapeutics: Buy Rating Affirmed Despite Challenges and Market Adjustments
12d ago
SRPT
Sarepta price target lowered to $113 from $182 at Morgan Stanley
Premium
The Fly
Sarepta price target lowered to $113 from $182 at Morgan Stanley
12d ago
SRPT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >